[Ki-67 antigen, a cell cycle and tumor growth marker]
- PMID: 1666669
[Ki-67 antigen, a cell cycle and tumor growth marker]
Abstract
The Ki-67 antigen is a cell cycle and tumor growth marker, which can be readily detected using immunocytochemistry methods. Ki-67 antigen is present only in the nuclei of cycling cells and is variably expressed as the cell goes through the various phases of the cycle: both the amount and the topographic distribution of Ki-67 antigen vary in a manner which is sufficiently specific to establish the precise cycle phase for each member of a cell population. From G1 through mitosis, the amount of Ki-67 antigen increases steadily: location of the antigen is nucleolar during G1 and both nucleolar and karyoplasmic during G2. The Ki-67 antigen is widely used to estimate the growth fraction of a tumor cell population; in many malignancies, the percentage of Ki-67-positive cells is correlated with parameters reflecting tumor aggressiveness or progression. These findings demonstrate the potential value of the Ki-67 antigen for the cytopathological or histopathological study of tumors, although neither its biochemical structure nor its function have been fully elucidated to date.
Similar articles
-
Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7).Anal Cell Pathol. 1989 Feb;1(1):25-39. Anal Cell Pathol. 1989. PMID: 2488698
-
Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.Anticancer Res. 1991 Nov-Dec;11(6):2015-21. Anticancer Res. 1991. PMID: 1776834
-
Ki-67 labeling in postmitotic cells defines different Ki-67 pathways within the 2c compartment.Cytometry. 1991;12(5):455-63. doi: 10.1002/cyto.990120511. Cytometry. 1991. PMID: 1935459
-
Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies.Semin Cancer Biol. 1990 Jun;1(3):199-206. Semin Cancer Biol. 1990. PMID: 2103495 Review.
-
The Ki-67 protein: from the known and the unknown.J Cell Physiol. 2000 Mar;182(3):311-22. doi: 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9. J Cell Physiol. 2000. PMID: 10653597 Review.
Cited by
-
Effect of Ribonuclease A and Deoxyribonuclease I on Immunostaining of Ki-67 in Cultured Melanoma Cells.Pathol Oncol Res. 1996;2(1-2):63-65. doi: 10.1007/BF02893952. Pathol Oncol Res. 1996. PMID: 11173587
-
Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.Br J Cancer. 2004 Dec 13;91(12):2018-25. doi: 10.1038/sj.bjc.6602233. Br J Cancer. 2004. PMID: 15545971 Free PMC article.
-
LINE-1 retrotransposition events affect endothelial proliferation and migration.Histochem Cell Biol. 2010 Dec;134(6):581-9. doi: 10.1007/s00418-010-0758-y. Epub 2010 Nov 11. Histochem Cell Biol. 2010. PMID: 21069374
-
Features of the Antitumor Effect of Vaccinia Virus Lister Strain.Viruses. 2016 Jan 12;8(1):20. doi: 10.3390/v8010020. Viruses. 2016. PMID: 26771631 Free PMC article.
-
Ki-67 expression in pulmonary tumors.Transl Lung Cancer Res. 2016 Oct;5(5):547-551. doi: 10.21037/tlcr.2016.10.13. Transl Lung Cancer Res. 2016. PMID: 27827465 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical